129 related articles for article (PubMed ID: 11855781)
1. Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma in children.
Pituch-Noworolska A; Hajto B; Balwierz W; Klus K
Haematologia (Budap); 2001; 31(3):191-207. PubMed ID: 11855781
[TBL] [Abstract][Full Text] [Related]
2. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
3. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
4. BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.
Haarman EG; Kaspers GJ; Pieters R; van Zantwijk CH; Broekema GJ; Hählen K; Veerman AJ
Adv Exp Med Biol; 1999; 457():325-33. PubMed ID: 10500808
[TBL] [Abstract][Full Text] [Related]
5. Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: a mitochondrial controlled pathway regulated by reactive oxygen species?
Groninger E; Meeuwsen-De Boer GJ; De Graaf SS; Kamps WA; De Bont ES
Int J Oncol; 2002 Dec; 21(6):1339-45. PubMed ID: 12429986
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.
Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z
Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962
[TBL] [Abstract][Full Text] [Related]
7. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.
Reisbach G; Kamp T; Welzl G; Geiz C; Abedinpour Fariborz ; Lodri A; Kaboth W; Dörmer P; Nerl C
Br J Haematol; 1996 Mar; 92(4):907-12. PubMed ID: 8616084
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
[TBL] [Abstract][Full Text] [Related]
10. Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.
Den Boer ML; Kapaun P; Pieters R; Kazemier KM; Janka-Schaub GE; Veerman AJ
Br J Haematol; 1999 Jun; 105(4):876-82. PubMed ID: 10554796
[TBL] [Abstract][Full Text] [Related]
11. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
12. [A study on the expression of myeloid cell leukemia 1 proteins and survivin and their relation with B cell apoptosis in non-Hodgkin's lymphoma].
Zuo XL; Zhou X; Meng J; Zhang KJ; Liu XH; Yang HQ
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):133-5. PubMed ID: 16624124
[TBL] [Abstract][Full Text] [Related]
13. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
[TBL] [Abstract][Full Text] [Related]
14. The Bax alpha:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia.
Salomons GS; Brady HJ; Verwijs-Janssen M; Van Den Berg JD; Hart AA; Van Den Berg H; Behrendt H; Hählen K; Smets LA
Int J Cancer; 1997 Jun; 71(6):959-65. PubMed ID: 9185697
[TBL] [Abstract][Full Text] [Related]
15. Fine-needle aspiration of non-Hodgkin's lymphoma. Southern blot analysis for antigen receptor, bcl-2, and c-myc gene rearrangements.
Williams ME; Frierson HF; Tabbarah S; Ennis PS
Am J Clin Pathol; 1990 Jun; 93(6):754-9. PubMed ID: 2189291
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia.
Srinivas G; Kusumakumary P; Nair MK; Panicker KR; Pillai MR
J Cancer Res Clin Oncol; 2000 Jan; 126(1):62-7. PubMed ID: 10641752
[TBL] [Abstract][Full Text] [Related]
17. Ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases.
Vang R; Medeiros LJ; Warnke RA; Higgins JP; Deavers MT
Mod Pathol; 2001 Nov; 14(11):1093-9. PubMed ID: 11706069
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma].
Li L; Su LP; Ma L; Zhao J; Zhu L; Zhou YA
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):199-202. PubMed ID: 19615260
[TBL] [Abstract][Full Text] [Related]
19. MBR rearrangement and P-glycoprotein expression are not independent prognostic factors like p53 protein in malignant lymphoma.
Sun RX; Coste J; Segara C; Rousset T; Fabbro M; Rème T; Legouffe E; Klein B; Rossi JF
Clin Lab Haematol; 1998 Apr; 20(2):87-94. PubMed ID: 9681218
[TBL] [Abstract][Full Text] [Related]
20. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy.
Watanabe A; Inukai T; Kagami K; Abe M; Takagi M; Fukushima T; Fukushima H; Nanmoku T; Terui K; Ito T; Toki T; Ito E; Fujimura J; Goto H; Endo M; Look T; Kamps M; Minegishi M; Takita J; Inaba T; Takahashi H; Ohara A; Harama D; Shinohara T; Somazu S; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2019 Sep; 8(11):5274-5288. PubMed ID: 31305009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]